Contact
Please use this form to send email to PR contact of this press release:
ALZHEIMER’S DRUG DISCOVERY FOUNDATION’S DIAGNOSTICS ACCELERATOR (DXA) Invests $1.4M in ViewMind’s technology.
TO:
Craig Davidson
Sermelo
+44 20 7240 6800